Recommended prophylactic regimens and their levels of evidence
| Drug used on patient population . | Dosage . | Level of evidence . |
|---|---|---|
| Conventional chemotherapy | ||
| Fluconazole | 50–400 mg qd PO | CI |
| Itraconazole oral suspension | 5 mg/kg qd | BI |
| Amphotericin B desoxycholate | 1.0 mg/kg/48h IV | CII |
| Amphotericin B desoxycholate | 20 mg inhalation | CI |
| Allogeneic transplantation | ||
| Fluconazole | 400 mg qd PO | AI |
| Fluconazole | 50–200 mg qd PO | CI |
| Liposomal amphotericin B | 1.0 mg/kg qd IV | CI |
| Drug used on patient population . | Dosage . | Level of evidence . |
|---|---|---|
| Conventional chemotherapy | ||
| Fluconazole | 50–400 mg qd PO | CI |
| Itraconazole oral suspension | 5 mg/kg qd | BI |
| Amphotericin B desoxycholate | 1.0 mg/kg/48h IV | CII |
| Amphotericin B desoxycholate | 20 mg inhalation | CI |
| Allogeneic transplantation | ||
| Fluconazole | 400 mg qd PO | AI |
| Fluconazole | 50–200 mg qd PO | CI |
| Liposomal amphotericin B | 1.0 mg/kg qd IV | CI |
PO indicates orally; IV, intravenously; and qd, once daily.